Head and Neck Cancer: Radiation Therapy With or Without Cisplatin in Treating Patients
With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone
Do the changes in a gene called TP53 influence the response to radiation therapy alone
or radiation therapy in combination with cisplatin chemotherapy?
Basic Study Information
Purpose:Location: Cancer Center
The purpose of this study is to compare two treatment approaches that are currently
used after surgery for head and neck cancer. One approach is to administer radiation
therapy alone. A second approach is to administer radiation therapy along with the
chemotherapy drug, cisplatin.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02734537?term=ea3132&rank=1
Study Reference #: CHAN17022
Lead Researcher (Principal Investigator)
Lead Researcher: Ronald Maggiore
Study Contact InformationStudy Coordinator: Park Bogan
Phone: (585) 276-4415
Additional Study Details
Learn More About These Conditions
More information about Carcinoma, Squamous Cell
Trial Not Found
The study you are looking for is not active at this time.
Return to Search